2252.HK

Surgical robot developer Shanghai MicroPort MedBot (Group) Co. Ltd. (2252.HK) on Tuesday announced it placed 34.7 million new shares, or about 3.45% of its enlarged share capital, at a price of HK$7.85 per share, raising approximately HK$272 million ($34.9 million). The price represented a discount of about 20% to Monday’s closing price of HK$9.81.

The company said it intends to use 70% of the approximately HK$266 million in net proceeds to develop its core business, including R&D to enhance and upgrade its products, as well as for commercialization of its products overseas. It will use the remaining 30% for supplementary working capital and general corporate purposes.

This marks the company’s second share placement this year. In June, it raised HK$117 million through a placement at a nearly 15% discount.

MicroPort MedBot’s stock opened 3.5% lower at HK$9.47 on Tuesday, closing down 13.7% at HK$8.47 by the midday break.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

Recent Articles

Illustration of the rebound of Chinese fintech lenders

A fintech lender rebound, and a hotel mess

Fintech lenders are entering a new golden era, with Jiayin reporting 46% growth for its core consumer lending business in last year's fourth quarter and forecasting similar gains this year. What's driving this rebound? And hotelier H World is still trying to fix a German acquisition from 2019 that wiped out its profit in the fourth quarter of last year. Will the Chinese hotelier be able to turn around this money-losing offshore asset?